{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:22:20Z","timestamp":1793935340306,"version":"4.8.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Left atrial appendage occlusion (LAAO) is an alternative to anticoagulation for stroke prevention in select patients with atrial fibrillation (AF). In this study, we describe the case of a patient with delayed device-related thrombus (DRT) at 13 months post-LAAO in a setting of atrial stasis due to a worsening mitral bioprosthetic stenosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 69-year-old woman with a history of rheumatic mitral stenosis and regurgitation post-bioprosthetic mitral valve replacement (6 years prior) and paroxysmal AF was referred for percutaneous LAAO due to recurrent severe gastrointestinal bleeding while on anticoagulation. She underwent an uncomplicated LAAO, for which a 35\u2005mm Watchman Flx device was used. Peri-procedural transoesophageal echocardiogram (TEE) at the time of implant showed thickened and calcified mitral bioprosthetic leaflets and a mild mitral stenosis. Her 45-day post-LAAO TEE showed a mild mitral stenosis and no peri-device leak or DRT. At 12 months, the patient had worsening exertional dyspnoea and pedal oedema. Her 12-month transthoracic echocardiogram (TTE) showed a moderate mitral stenosis and LAAO remained free of DRT. Her symptoms were deemed secondary from a worsening mitral valve stenosis. Mitral valve-in-valve (MViV) replacement was planned because the patient was deemed a prohibitive risk for a redo surgical replacement. Transthoracic echocardiogram on the day of MViV showed a large thrombus on the LAAO device. MViV was postponed. After the patient completed 45 days of anticoagulation with warfarin, a repeat TTE was performed, which showed a resolution of DRT. Transcatheter MViV was performed successfully.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This case demonstrates that increased stasis and left atrial dysfunction from prosthetic mitral stenosis can be a risk factor for late DRT after successful LAAO. The use of a LAAO occlusion device in the presence of a mitral bioprosthesis requires more frequent echocardiographic monitoring to assess both the function of the prosthesis and a delayed formation of thrombus. More studies need to be conducted to assess the safety of percutaneous LAAO devices in those with mitral bioprosthesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae438","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:31:48Z","timestamp":1724459508000},"source":"Crossref","is-referenced-by-count":3,"title":["Late-onset left atrial appendage occlusion device\u2013related thrombus attributed to mitral bioprosthetic stenosis: a case report"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4167-1164","authenticated-orcid":false,"given":"Aakash","family":"Rana","sequence":"first","affiliation":[{"name":"Central Arkansas Veterans Affairs Health System , 4300, W 7th Street, Little Rock, AR 72205 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Xu","sequence":"additional","affiliation":[{"name":"Novant Health Forsyth Medical Center , Winston-Salem, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alturkmani","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences , 6301 West Markham St, Slot 532, Little Rock, AR 72205 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Dhar","sequence":"additional","affiliation":[{"name":"Rush University Medical Center , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2404-1152","authenticated-orcid":false,"given":"Srikanth","family":"Vallurupalli","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences , 6301 West Markham St, Slot 532, Little Rock, AR 72205 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"2024091010420593800_ytae438-B1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024091010420593800_ytae438-B2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024091010420593800_ytae438-B3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"2024091010420593800_ytae438-B4","doi-asserted-by":"crossref","first-page":"e010195","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2024091010420593800_ytae438-B5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"2024091010420593800_ytae438-B6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2024091010420593800_ytae438-B7","doi-asserted-by":"crossref","first-page":"e008112","DOI":"10.1161\/CIRCINTERVENTIONS.119.008112","article-title":"Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography","volume":"12","author":"Korsholm","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2024091010420593800_ytae438-B8","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jcin.2020.06.056","article-title":"Procedural and short-term results with the New Watchman FLX left atrial appendage occlusion device","volume":"13","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2024091010420593800_ytae438-B9","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1002\/ccd.29458","article-title":"Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-insights from the EWOLUTION real world registry","volume":"97","author":"Sedaghat","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2024091010420593800_ytae438-B10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024091010420593800_ytae438-B11","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"2024091010420593800_ytae438-B12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4022\/jafib.1524","article-title":"Percutaneous left atrial appendage closure: is there a role in valvular atrial fibrillation","volume":"9","author":"Huded","year":"2017","journal-title":"J Atr Fibrillation"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae438\/58902063\/ytae438.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/9\/ytae438\/59070837\/ytae438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/9\/ytae438\/59070837\/ytae438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:37:44Z","timestamp":1725971864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae438\/7739652"}},"subtitle":[],"editor":[{"given":"Dimitrios A","family":"Vrachatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Martin","family":"Manninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Henrike Aenne Katrin","family":"Hillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Tom","family":"Wardill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae438","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,23]]},"article-number":"ytae438"}}